![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24937 |
FusionGeneSummary for NSMCE1_IL4R |
![]() |
Fusion gene information | Fusion gene name: NSMCE1_IL4R | Fusion gene ID: 24937 | Hgene | Tgene | Gene symbol | NSMCE1 | IL4R | Gene ID | 197370 | 3566 |
Gene name | NSE1 homolog, SMC5-SMC6 complex component | interleukin 4 receptor | |
Synonyms | NSE1 | CD124|IL-4RA|IL4RA | |
Cytomap | 16p12.1 | 16p12.1 | |
Type of gene | protein-coding | protein-coding | |
Description | non-structural maintenance of chromosomes element 1 homolognon-SMC element 1 homolog | interleukin-4 receptor subunit alphaIL-4 receptor subunit alphaIL4R nirs variant 1interleukin 13 receptorinterleukin-4 receptor alpha chain | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q8WV22 | P24394 | |
Ensembl transtripts involved in fusion gene | ENST00000361439, ENST00000565384, | ENST00000395762, ENST00000543915, ENST00000449195, ENST00000380922, ENST00000170630, ENST00000565915, | |
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 3 X 3 X 2=18 |
# samples | 5 | 3 | |
** MAII score | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: NSMCE1 [Title/Abstract] AND IL4R [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SKCM | TCGA-BF-A1Q0-01A | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000361439 | ENST00000395762 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
In-frame | ENST00000361439 | ENST00000543915 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
5CDS-intron | ENST00000361439 | ENST00000449195 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
5CDS-intron | ENST00000361439 | ENST00000380922 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
5CDS-intron | ENST00000361439 | ENST00000170630 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
5CDS-3UTR | ENST00000361439 | ENST00000565915 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-3CDS | ENST00000565384 | ENST00000395762 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-3CDS | ENST00000565384 | ENST00000543915 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-intron | ENST00000565384 | ENST00000449195 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-intron | ENST00000565384 | ENST00000380922 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-intron | ENST00000565384 | ENST00000170630 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
intron-3UTR | ENST00000565384 | ENST00000565915 | NSMCE1 | chr16 | 27268756 | - | IL4R | chr16 | 27367129 | + |
Top |
FusionProtFeatures for NSMCE1_IL4R |
![]() |
Hgene | Tgene |
NSMCE1 | IL4R |
RING-type zinc finger-containing E3 ubiquitin ligasethat assembles with melanoma antigen protein (MAGE) to catalyzethe direct transfer of ubiquitin from E2 ubiquitin-conjugatingenzyme to a specific substrate. Within MAGE-RING ubiquitin ligasecomplex, MAGE stimulates and specifies ubiquitin ligase activitylikely through recruitment and/or stabilization of the E2ubiquitin-conjugating enzyme at the E3:substrate complex. Involvedin maintenance of genome integrity, DNA damage response and DNArepair (PubMed:29225034, PubMed:20864041). NSMCE3/MAGEG1 andNSMCE1 ubiquitin ligase are components of SMC5-SMC6 complex andmay positively regulate homologous recombination-mediated DNArepair (PubMed:18086888). MAGEF1-NSMCE1 ubiquitin ligase promotesproteasomal degradation of MMS19, a key component of the cytosoliciron-sulfur protein assembly (CIA) machinery. Down-regulation ofMMS19 impairs the activity of several DNA repair and metabolismenzymes such as ERCC2/XPD, FANCJ, RTEL1 and POLD1 that requireiron-sulfur clusters as cofactors (PubMed:29225034).{ECO:0000269|PubMed:18086888, ECO:0000269|PubMed:20864041,ECO:0000269|PubMed:29225034}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 370_380 | 223 | 826 | Compositional bias | Note=Poly-Glu |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 563_566 | 223 | 826 | Compositional bias | Note=Poly-Ala |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 789_794 | 223 | 826 | Compositional bias | Note=Poly-Ser |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 370_380 | 223 | 826 | Compositional bias | Note=Poly-Glu |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 563_566 | 223 | 826 | Compositional bias | Note=Poly-Ala |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 789_794 | 223 | 826 | Compositional bias | Note=Poly-Ser |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 370_380 | -81 | 228 | Compositional bias | Note=Poly-Glu |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 563_566 | -81 | 228 | Compositional bias | Note=Poly-Ala |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 789_794 | -81 | 228 | Compositional bias | Note=Poly-Ser |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 370_380 | 223 | 826 | Compositional bias | Note=Poly-Glu |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 563_566 | 223 | 826 | Compositional bias | Note=Poly-Ala |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 789_794 | 223 | 826 | Compositional bias | Note=Poly-Ser |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 125_224 | -81 | 228 | Domain | Fibronectin type-III |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 262_270 | 223 | 826 | Motif | Note=Box 1 motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 711_716 | 223 | 826 | Motif | Note=ITIM motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 262_270 | 223 | 826 | Motif | Note=Box 1 motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 711_716 | 223 | 826 | Motif | Note=ITIM motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 212_216 | -81 | 228 | Motif | Note=WSXWS motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 262_270 | -81 | 228 | Motif | Note=Box 1 motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 711_716 | -81 | 228 | Motif | Note=ITIM motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 262_270 | 223 | 826 | Motif | Note=Box 1 motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 711_716 | 223 | 826 | Motif | Note=ITIM motif |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 437_557 | 223 | 826 | Region | Note=Required for IRS1 activation and IL4-induced cell growth |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 558_657 | 223 | 826 | Region | Note=Required for IL4-induced gene expression |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 437_557 | 223 | 826 | Region | Note=Required for IRS1 activation and IL4-induced cell growth |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 558_657 | 223 | 826 | Region | Note=Required for IL4-induced gene expression |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 437_557 | -81 | 228 | Region | Note=Required for IRS1 activation and IL4-induced cell growth |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 558_657 | -81 | 228 | Region | Note=Required for IL4-induced gene expression |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 437_557 | 223 | 826 | Region | Note=Required for IRS1 activation and IL4-induced cell growth |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 558_657 | 223 | 826 | Region | Note=Required for IL4-induced gene expression |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 257_825 | 223 | 826 | Topological domain | Cytoplasmic |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 257_825 | 223 | 826 | Topological domain | Cytoplasmic |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 257_825 | -81 | 228 | Topological domain | Cytoplasmic |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 26_232 | -81 | 228 | Topological domain | Extracellular |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 257_825 | 223 | 826 | Topological domain | Cytoplasmic |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 233_256 | 223 | 826 | Transmembrane | Helical |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 233_256 | 223 | 826 | Transmembrane | Helical |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000449195 | + | 0 | 8 | 233_256 | -81 | 228 | Transmembrane | Helical |
Tgene | >IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 233_256 | 223 | 826 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >NSMCE1 | chr16:27268756 | chr16:27367129 | ENST00000361439 | - | 2 | 8 | 191_232 | 45 | 267 | Zinc finger | RING-type%3B atypical |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 125_224 | 223 | 826 | Domain | Fibronectin type-III |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 125_224 | 223 | 826 | Domain | Fibronectin type-III |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 125_224 | 223 | 826 | Domain | Fibronectin type-III |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 212_216 | 223 | 826 | Motif | Note=WSXWS motif |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 212_216 | 223 | 826 | Motif | Note=WSXWS motif |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 212_216 | 223 | 826 | Motif | Note=WSXWS motif |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000170630 | + | 4 | 9 | 26_232 | 223 | 826 | Topological domain | Extracellular |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000395762 | + | 6 | 11 | 26_232 | 223 | 826 | Topological domain | Extracellular |
Tgene | IL4R | chr16:27268756 | chr16:27367129 | ENST00000543915 | + | 5 | 10 | 26_232 | 223 | 826 | Topological domain | Extracellular |
Top |
FusionGeneSequence for NSMCE1_IL4R |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NSMCE1_IL4R |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NSMCE1 | NDNL2, MAGEF1, SMC6, NSMCE2, NSMCE4A, EID3, SMC5, NSMCE1, UBC, UBE2D2, PMF1, SIMC1, FAM178A, OBFC1, ZNF597, MAGEB10 | IL4R | GNB2L1, ARIH2, SHC1, PTPN6, INPP5D, PTPN11, IL4, JAK1, NCF1, HGS, KAT5, IL2RG, SOCS5, STAT6, JAK2, JAK3, CD40, RHBDF2, ANKLE2, NET1, PRR11, TYK2, UTP6, KCNT2, PKMYT1, STX5, GOLGA2, DHRS3, RHOBTB3, ACVR2B, PLEKHH3, ZDHHC9, DCAKD, TNFRSF10A, RELT, BMPR1A, ERBB2, ARL5B |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | NSMCE1 | chr16:27268756 | chr16:27367129 | ENST00000361439 | - | 2 | 8 | 1_102 | 45 | 267 | NSMCE3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NSMCE1_IL4R |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NSMCE1_IL4R |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | IL4R | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |